NCT02959996View on ClinicalTrials.gov

Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 8, 2017

Primary Completion Date

September 25, 2017

Study Completion Date

November 3, 2017

Conditions
Pain, Postoperative
Interventions
DRUG

Liposomal bupivacaine

liposomal bupivacaine injection in the Pfannenstiel incision

DRUG

Placebo

placebo injection in the Pfannenstiel incision

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02959996 - Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain | Biotech Hunter | Biotech Hunter